Surgical approaches to autologous limbal stem cell transplantation (LSCT) following severe corneal chemical burns

Abstract

Chemical injury of the conjunctiva and cornea are true ocular emergencies and require immediate intervention. They can produce severe, extensive ocular damage, including limbal stem cell deficiency (LSCD), and lead to irreversible visual loss. LSCD can be treated surgically through autologous limbal stem cell transplantation (LSCT). Autologous LSCT can be performed through cultivated limbal epithelial transplantation (CLET) or by direct grafting of limbal epithelial cells through conjunctival-limbal autografting (CLAU) or simple limbal epithelial transplantation (SLET). In this review we provide an overview of each surgical approach. CLET allows for a implantation of a large graft in the recipient eye while preserving donor cells. Its success rate is higher with an increased number of transplanted stem cells; failures tend to occur within the first year. CLAU is performed by directly transplanting autologous limbal stem cells from the patient's healthy eye, reducing the risk of immune rejection. This constitutes a risk for the donor eye, as the removal of stem cells from the fellow eye may lead to LSCD in the donor eye. SLET consists of direct implantation of donor stem cells on an amniotic membrane, thus avoiding the need for ex-vivo expansion. Combinations of CLAU and SLET within a single procedure have also been successfully utilized. Autologous LCST is an effective technique for surgical management of unilateral LCSD. Depending on the patient history and status of the fellow eye, either CLET, CLAU or SLET (including the combination of mini-CLAU and SLET) can be used to restore long-term function and prevent visual impairment.